Source:http://linkedlifedata.com/resource/pubmed/id/11514403
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-8-21
|
pubmed:abstractText |
In transplant patients, current cyclosporine (CsA) dose monitoring with classic pharmacokinetics has demonstrated limitations. Evaluation of the activity of calcineurin (CN), the serine-threonine phosphatase enzyme target of CsA, has been proposed as a reliable way to optimize CsA dosing.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1679-87
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11514403-Buffers,
pubmed-meshheading:11514403-Calcineurin,
pubmed-meshheading:11514403-Cyclosporine,
pubmed-meshheading:11514403-Humans,
pubmed-meshheading:11514403-Immunosuppressive Agents,
pubmed-meshheading:11514403-Kidney Transplantation,
pubmed-meshheading:11514403-Reproducibility of Results
|
pubmed:year |
2001
|
pubmed:articleTitle |
Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients.
|
pubmed:affiliation |
Department of Immunology and Clinics of Organ Transplantation, Ospedali Riuniti di Bergamo, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy.
|
pubmed:publicationType |
Journal Article
|